A. Nattermann & Cie Gmbh

Other

Solco Basel Ag

Dpc Biermann Gmbh

Albrecht Wendel

Norbert Dereu

Sigurd Leyck

Andre Welter

Erich Graf

Thomas Hartung

Helmut Sies

Eugen Etschenberg

Richard R Schmidt

Hans Betzing

Michael J Parnham

Axel Romer

Hartmut Fischer

Leon Christiaens

Harmut Fischer

Peter Zimmerman

Peter Kuhl

Eric Graf

Thomas Baer

Preparations containing deep-frozen blood are used for test procedures for determining blood response.

Biological system to test in vitro if a substance is immune reactive

A method of ascertaining the pyrogenicity of a material involves exposing to the material a sample of whole blood from a human or an amimal, followed by determining whether the exposure induces formation of endogenous pyrogen in the sample.

Test for determining pyrogenic effect of a material

The compounds of the formula I exert a pronounced specific cytoprotective effect; they can be used for the treatment of acute and chronic inflammations and organ ischemias caused by narrowing of vessels. R.sup.1 denotes an aliphatic radical having 9 to 19 C atoms in the straight chain, R.sup.2 denotes the acyl radical of a saturated or unsaturated fatty acid having 14 to 24 C atoms, and X denotes a --CH.sub.2 CH.sub.2 --or --CH.dbd.CH-- group. The invention relates to pharmaceutical products in which the active ingredient is the said compounds, as well as to those compounds I in which R.sup.2 denotes the acyl radical of an unsaturated fatty acid, and to the process for the preparation thereof. ##STR1##

Pharmaceutical products and lactosyl compounds

The present invention relates to new diselenobis-benzoic acid amides of primary and secondary amines of the general formula (I): ##STR1## and processes for the treatment of diseases in humans caused by a cell injury.

Diselenobis-benzoic acid amides of primary and secondary amines and

The present invention is related to new S-(Carbamoyl-phenylselenyl) derivatives of mercaptanes of the general formula (I) ##STR1## and to a process for the treatment of diseases caused by cell injury due to the increased formation of active oxygen metabolites.

S-[2-phenyl (alkyl) carbamoyl]-phenylselenylmercapto derivatives

The present invention relates to new S-(carbamoylphenylselenyl) derivatives of glutathione and of .alpha.-aminomercaptocarboxylic acids of the general formula (I) ##STR1##

S-(carbamoyl-phenylselenyl) derivatives of glutathione and of

Growing community of inventors

Tubingen, Germany

Albrecht Wendel